| 查看: 101 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[资源]
美国联邦法案210、211部分内容变更
|
|||
|
美国联邦法案210、211部分内容变更，2008年12月8日开始实施，摘要如下，具体内容见附件（英文）： The Food and Drug Administration (FDA) is amending certain of its regulations on current good manufacturing practice (CGMP) requirements for finished pharmaceuticals as the culmination of the first phase of an incremental approach to modifying the CGMP regulations for these products. This rule revises CGMP requirements primarily concerning aseptic processing, verification of performance of operations by a second individual, and the use of asbestos filters. We are amending the regulations to modernize or clarify some of the requirements as well as to harmonize them with other FDA regulations and international CGMP standards. [search]美国210、211[/search] |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有5人回复
-
2027博士申请-临床检验诊断学、病原生物学、微生物方向
已经有5人回复
-
【长期招聘】复旦大学 AI 制药实验室 博士后招聘
已经有10人回复
-
各位基础老师们，看完中央《从严治党》的决定后，对学术界更加有信心了吧
已经有4人回复
-
越来越担心硕士毕业后没有竞争力了
已经有15人回复
-
申博自荐 2篇一区TOP+1篇EI+2公开发明专利 2027博士申请
已经有3人回复